<DOC>
	<DOCNO>NCT00152711</DOCNO>
	<brief_summary>This study aim evaluate impact nasal continuous positive airway pressure ( nCPAP ) treatment liver enzymes patient sleep apnea syndrome nonalcoholic steatohepatitis . Using cross design , evolution liver enzymes evaluate 40 patient consecutive period 6 week , without nCPAP treatment .</brief_summary>
	<brief_title>Impact nCPAP Treatment Liver Function Patients With Sleep Apnea Syndrome Nonalcoholic Steatohepatitis</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>18 70 year old Nonalcoholic steatohepatitis proven liver biopsy Sleep apnea syndrome proven polysomnography apneahypopnea index &gt; 10 events/hour Informed consent Psychiatric disorder Other cause liver disease Professional driver</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>